These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1607699)

  • 1. Persistence of measles antibody after revaccination.
    Markowitz LE; Albrecht P; Orenstein WA; Lett SM; Pugliese TJ; Farrell D
    J Infect Dis; 1992 Jul; 166(1):205-8. PubMed ID: 1607699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.
    Ward BJ; Boulianne N; Ratnam S; Guiot MC; Couillard M; De Serres G
    J Infect Dis; 1995 Dec; 172(6):1591-5. PubMed ID: 7594723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test.
    Ward BJ; Aouchiche S; Martel N; Bertley FM; Bautista-Lopez N; Serhir B; Ratnam S
    Diagn Microbiol Infect Dis; 1999 Mar; 33(3):147-52. PubMed ID: 10092962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
    Ratnam S; Gadag V; West R; Burris J; Oates E; Stead F; Bouilianne N
    J Clin Microbiol; 1995 Apr; 33(4):811-5. PubMed ID: 7790442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles antibody: reevaluation of protective titers.
    Chen RT; Markowitz LE; Albrecht P; Stewart JA; Mofenson LM; Preblud SR; Orenstein WA
    J Infect Dis; 1990 Nov; 162(5):1036-42. PubMed ID: 2230231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to measles revaccination among Bolivian school-aged children.
    Bartoloni A; Cutts FT; Guglielmetti P; Brown D; Bianchi Bandinelli ML; Hurtado H; Roselli M
    Trans R Soc Trop Med Hyg; 1997; 91(6):716-8. PubMed ID: 9509188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
    Dilraj A; Cutts FT; Bennett JV; Fernandez de Castro J; Cohen B; Coovadia HM
    Pediatr Infect Dis J; 2000 Dec; 19(12):1211-3. PubMed ID: 11144388
    [No Abstract]   [Full Text] [Related]  

  • 11. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.
    Bertley FM; Ibrahim SA; Libman M; Ward BJ
    Vaccine; 2004 Dec; 23(4):444-9. PubMed ID: 15530692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
    Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
    Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
    J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Qin M; Levin MJ; Fenton T; Beeler JA; Bellini WJ; Audet S; Sowers SB; Borkowsky W; Nachman SA; Pelton SI; Rosenblatt HM;
    J Infect Dis; 2012 Aug; 206(4):512-22. PubMed ID: 22693229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults.
    Cohn ML; Robinson ED; Faerber M; Thomas D; Geyer S; Peters S; Martin M; Martin A; Sobel D; Jones R
    Pediatr Infect Dis J; 1994 Jan; 13(1):34-8. PubMed ID: 8170730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revaccination against measles--a pilot study.
    Watson GI; Nichols JA; Robshaw JR
    J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
    Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
    J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles revaccination. Persistence and degree of antibody titer by type of immune response.
    Deseda-Tous J; Cherry JD; Spencer MJ; Welliver RC; Boyer KM; Dudley JP; Zahradnik JM; Krause PJ; Walbergh EW
    Am J Dis Child; 1978 Mar; 132(3):287-90. PubMed ID: 629246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.